Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

[Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].

Knappik M, Schönfeld N, Günther A, Bergmann T, Magdorf K, Rüssmann H, Mauch H, Barker M.

Pneumologie. 2012 Apr;66(4):207-11. doi: 10.1055/s-0032-1308914. Epub 2012 Apr 4. German.

2.

Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.

Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S.

Lupus. 2012 Apr;21(5):491-5. doi: 10.1177/0961203311430700. Epub 2011 Dec 2.

PMID:
22140142
3.

Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.

Kleinert S, Tony HP, Krueger K, Detert J, Mielke F, Rockwitz K, Schwenke R, Burmester GR, Diel R, Feuchtenberger M, Kneitz C.

Ann Rheum Dis. 2012 Nov;71(11):1791-5. doi: 10.1136/annrheumdis-2011-200941. Epub 2012 May 14.

PMID:
22586160
4.

The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H.

Pediatr Infect Dis J. 2011 Aug;30(8):694-700. doi: 10.1097/INF.0b013e318214b915.

PMID:
21427627
5.
6.
7.

Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.

Wolf T, Goetsch U, Oremek G, Bickel M, Khaykin P, Haberl A, Bellinger O, Gottschalk R, Brodt HR, Stephan C.

J Infect. 2013 Apr;66(4):376-80. doi: 10.1016/j.jinf.2012.11.004. Epub 2012 Nov 15.

PMID:
23159357
8.

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.

Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M.

BMC Infect Dis. 2011 Nov 15;11:319. doi: 10.1186/1471-2334-11-319.

9.

How to use: interferon γ release assays for tuberculosis.

Pollock L, Basu Roy R, Kampmann B.

Arch Dis Child Educ Pract Ed. 2013 Jun;98(3):99-105. doi: 10.1136/archdischild-2013-303641. Epub 2013 Apr 11. Review.

PMID:
23580543
10.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
11.

Snapshot of Quantiferon TB gold testing in Northern Mexico.

González-Salazar F, Vargas-Villarreal J, Garcialuna-Martínez FJ, Rivera G, Moreno-Treviño MG, Montfort-Gardeazabal JM, Garcialuna-Martínez E.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S34-7. doi: 10.1016/j.tube.2011.10.007. Epub 2011 Nov 17.

PMID:
22099419
12.

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU.

Arthritis Rheum. 2012 Jul;64(7):2068-77. doi: 10.1002/art.34382.

13.

Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Mínguez S, Latorre I, Mateo L, Lacoma A, Diaz J, Olivé A, Domínguez J.

Clin Rheumatol. 2012 May;31(5):785-94. doi: 10.1007/s10067-012-1938-z. Epub 2012 Jan 21.

PMID:
22271230
14.

Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study.

Bamford AR, Crook AM, Clark JE, Nademi Z, Dixon G, Paton JY, Riddell A, Drobniewski F, Riordan A, Anderson ST, Williams A, Walters S, Kampmann B.

Arch Dis Child. 2010 Mar;95(3):180-6. doi: 10.1136/adc.2009.169805. Epub 2009 Oct 8.

PMID:
19815937
15.

Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.

Alsleben N, Ruhwald M, Rüssmann H, Marx FM, Wahn U, Magdorf K.

Scand J Infect Dis. 2012 Apr;44(4):256-62. doi: 10.3109/00365548.2011.632644. Epub 2011 Nov 21.

PMID:
22103555
16.

A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.

Campbell JR, Krot J, Elwood K, Cook V, Marra F.

Mol Diagn Ther. 2015 Feb;19(1):9-24. doi: 10.1007/s40291-014-0125-0. Review.

PMID:
25579159
17.

Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.

Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):95-101.

PMID:
22117500
18.

[Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].

Kuś J, Demkow U, Lewandowska K, Korzeniewska-Koseła M, Rabczenko D, Siemion-Szcześniak I, Białas-Chromiec B, Bychawska M, Sapigórski P, Maciejewski J.

Pneumonol Alergol Pol. 2011;79(6):407-18. Polish.

19.

Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.

Papay P, Primas C, Eser A, Novacek G, Winkler S, Frantal S, Angelberger S, Mikulits A, Dejaco C, Kazemi-Shirazi L, Vogelsang H, Reinisch W.

Aliment Pharmacol Ther. 2012 Nov;36(9):858-65.

20.

[Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis].

Komukai J, Matsumoto K, Tomihara A, Miyake Y, Tatsumi T, Arima K, Danno K, Hirota S, Yoshida H, Koda S, Terakawa K, Shimouchi A.

Kekkaku. 2011 Nov;86(11):847-56. Japanese.

PMID:
22250463
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk